Frontlight ResearchEarly access
Taking people in BulgariaPhase 1
Tests TU7710 safety in people with haemophilia A or B
Tests TU7710 in adults with haemophilia A or B for safety.
Key facts
- Who runs it
- Tiumbio Co. Ltd.
- Where
- Sofiya, BulgariaSee the siteAlso in 3 other countries, 5 sites
- Trial code
- Registry title
- A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 21 people, planned
- Started
- 10 Dec 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Record updated
- 18 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult men with haemophilia A or B.
- Age
- 18 years or older
- Sex
- Men only
Where in Bulgaria
Also in 3 other countries, 5 sites
- Specialized Hospital For Active Treatment Of Hematological Diseases EADSofiya, BulgariaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Tests TU7710 safety in people with haemophilia A or BGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 18 September 2026